The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004

BACKGROUND: For winter 2003/2004 in Scotland, it was recommended that all those aged 65 and over be eligible to receive 23-valent polysaccharide pneumococcal vaccine (23vPPV), which has been shown to be effective in reducing the risk of invasive pneumococcal disease (IPD). We assessed the success of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mooney, John D, Weir, Amanda, McMenamin, Jim, Ritchie, Lewis D, Macfarlane, Tatania V, Simpson, Colin R, Ahmed, Syed, Robertson, Chris, Clarke, Stuart C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386805/
https://www.ncbi.nlm.nih.gov/pubmed/18433473
http://dx.doi.org/10.1186/1471-2334-8-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386805/
https://www.ncbi.nlm.nih.gov/pubmed/18433473
http://dx.doi.org/10.1186/1471-2334-8-53

Ejemplares similares